Justin McCue
Directeur Technique/Scientifique/R&D chez TSCAN THERAPEUTICS, INC.
Profil
Justin McCue is currently the Chief Technology Officer at TScan Therapeutics, Inc. He previously held the position of Chief Technology Officer at Avectas Ltd.
and Vice President-Technical Operations at Repertoire Immune Medicines, Inc. Dr. McCue completed his undergraduate degree at the University of California, Berkeley.
Postes actifs de Justin McCue
| Sociétés | Poste | Début |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 04/12/2023 |
Anciens postes connus de Justin McCue
| Sociétés | Poste | Fin |
|---|---|---|
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Directeur Technique/Scientifique/R&D | - |
Avectas Ltd.
 Avectas Ltd. Miscellaneous Commercial ServicesCommercial Services Avectas Ltd. provides cellular biotechnology solutions. It develops cell engineering technology called Solupore which permeabilizes the target cell membrane and allows transfer of cargo into cells. The company was founded by Shirley O? Dea and Michael Maguire in 2012 and is headquartered in Kildare, Ireland. | Directeur Technique/Scientifique/R&D | - |
Formation de Justin McCue
| Massachusetts Institute of Technology | Doctorate Degree |
| University of California, Berkeley | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TSCAN THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Avectas Ltd.
Avectas Ltd. Miscellaneous Commercial ServicesCommercial Services Avectas Ltd. provides cellular biotechnology solutions. It develops cell engineering technology called Solupore which permeabilizes the target cell membrane and allows transfer of cargo into cells. The company was founded by Shirley O? Dea and Michael Maguire in 2012 and is headquartered in Kildare, Ireland. | Commercial Services |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Commercial Services |
